INTERVEXION THERAPEUTICS

InterveXion is a privately-held clinical-stage biopharmaceutical company developing novel product candidates for the treatment of addiction disorders. Their lead clinical asset is IXT-m200, a monoclonal antibody directed against methamphetamine, which acts by re-partitioning methamphetamine away from its sites of action in the CNS. IXT-m200 has received US FDA Fast Track Designation, and is being studied in an ongoing Phase 2 proof-of-concept study (STAMPOUT; NCT03336866). They are also developing a novel vaccine (IXT-v100) against methamphetamine, which is in Preclinical Development.

#SimilarOrganizations #People #Financial #Website #More

INTERVEXION THERAPEUTICS

Industry:

Biopharma Biotechnology Health Care Pharmaceutical

Founded:

2004-01-01

Address:

Little Rock, Arkansas, United States

Country:

United States

Website Url:

http://www.intervexion.com

Total Employee:

51+

Status:

Active

Contact:

501.554.2377

Total Funding:

52.8 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Mobile Non Scaleable Content Sitelinks Search Box Organization Schema Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins

Similar Organizations

adrenomed-logo

Adrenomed

Adrenomed is a privately-financed, clinical-stage biopharmaceutical company.

arbutus-biopharma-logo

Arbutus Biopharma

Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.

ascentage-pharma-logo

Ascentage Pharma

Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company.

cerebral-therapeutics-logo

Cerebral Therapeutics

Cerebral Therapeutics is a clinical-stage pharmaceutical company.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

corvus-pharmaceuticals-logo

Corvus Pharmaceuticals

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

enteris-biopharma-logo

Enteris BioPharma

Enteris BioPharma is a privately held, clinical stage biopharmaceutical company

inversago-pharma-logo

Inversago Pharma

Inversago Pharma is a specialized, preclinical-stage biotech company.

minerva-neuroscience-logo

Minerva Neuroscience

Minerva Neurosciences is a clinical-stage biopharmaceutical company

ocugen-logo

Ocugen

Ocugen is a clinical stage biopharmaceutical company.

union-therapeutics-as-logo

UNION therapeutics A/S

UNION therapeutics A/S is a privately held, clinical stage, pharmaceutical company.

Current Employees Featured

not_available_image

Gerald A. Damerow
Gerald A. Damerow Chief Financial Officer @ InterveXion Therapeutics
Chief Financial Officer

not_available_image

Keith Ward
Keith Ward President and Chief Executive Officer @ InterveXion Therapeutics
President and Chief Executive Officer
2019-05-01

not_available_image

Misty Ward Stevens
Misty Ward Stevens Chief Operating Officer @ InterveXion Therapeutics
Chief Operating Officer
2019-06-01

brooks-gentry_image

Brooks Gentry
Brooks Gentry Chief Medical Officer @ InterveXion Therapeutics
Chief Medical Officer
2003-01-01

s-michael-owens_image

S. Michael Owens
S. Michael Owens Chief Scientific Officer (CSO) @ InterveXion Therapeutics
Chief Scientific Officer (CSO)

ralph-henry_image

Ralph Henry
Ralph Henry Executive Vice President, Corporate Development and Biopharmaceutics @ InterveXion Therapeutics
Executive Vice President, Corporate Development and Biopharmaceutics
2004-01-01

Founder

ralph-henry_image

Ralph Henry

Investors List

national-institutes-of-health_image

Official Site Inspections

http://www.intervexion.com Semrush global rank: 9.72 M Semrush visits lastest month: 114

Host Informations
Whois Informations

Loading ...